NASDAQ:SLDB - Solid Biosciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$21.89 -0.82 (-3.61 %)
(As of 05/21/2018 01:17 AM ET)
Previous Close$21.89
Today's Range$21.61 - $22.9490
52-Week Range$6.83 - $33.74
Volume118,310 shs
Average Volume266,720 shs
Market Capitalization$776.26 million
P/E Ratio-7.60
Dividend YieldN/A
BetaN/A

About Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences logoSolid Biosciences Inc. engages in identifying and developing therapies for duchenne muscular dystrophy in the United States. Its lead product candidate includes SGT-001, a gene therapy that is in Phase I/II clinical trials to restore functional dystrophin protein expression in patients' muscles. The company's product candidates also comprise SB-001, a monoclonal antibody to reduce fibrosis and inflammation. In addition, it is developing soft wearable assistive devices that have functional and therapeutic benefits to DMD patients. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Receive SLDB News and Ratings via Email

Sign-up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SLDB
CUSIPN/A
Phone617-337-4680

Debt

Debt-to-Equity RatioN/A
Current Ratio18.59
Quick Ratio6.27

Price-To-Earnings

Trailing P/E Ratio-7.60
Forward P/E Ratio-9.95
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$5.05 per share
Price / Book4.33

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees60
Outstanding Shares35,460,000

Solid Biosciences (NASDAQ:SLDB) Frequently Asked Questions

What is Solid Biosciences' stock symbol?

Solid Biosciences trades on the NASDAQ under the ticker symbol "SLDB."

How were Solid Biosciences' earnings last quarter?

Solid Biosciences (NASDAQ:SLDB) announced its quarterly earnings data on Thursday, May, 10th. The company reported ($0.54) earnings per share for the quarter, beating analysts' consensus estimates of ($0.58) by $0.04. View Solid Biosciences' Earnings History.

When is Solid Biosciences' next earnings date?

Solid Biosciences is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Solid Biosciences.

What price target have analysts set for SLDB?

6 Wall Street analysts have issued 12 month price objectives for Solid Biosciences' stock. Their forecasts range from $28.00 to $52.00. On average, they expect Solid Biosciences' share price to reach $35.5833 in the next twelve months. View Analyst Ratings for Solid Biosciences.

Are investors shorting Solid Biosciences?

Solid Biosciences saw a decrease in short interest in the month of April. As of April 13th, there was short interest totalling 735,728 shares, a decrease of 42.3% from the March 30th total of 1,276,063 shares. Based on an average trading volume of 282,544 shares, the days-to-cover ratio is currently 2.6 days. Approximately 3.9% of the company's stock are sold short.

Who are some of Solid Biosciences' key competitors?

Who are Solid Biosciences' key executives?

Solid Biosciences' management team includes the folowing people:
  • Ms. Jennifer Ziolkowski CPA, CFO, Treasurer & Assistant Sec. (Age 44)
  • Dr. Jorge A. Quiroz M.D., Chief Medical Officer (Age 48)
  • Dr. Andrey Zarur Ph.D., Co-Founder & Chairman of Directors (Age 47)
  • Mr. Ilan Ganot, Co-Founder, CEO & Director (Age 44)
  • Mr. Gilad David Hayeem, Co-Founder, Pres & Director (Age 50)

When did Solid Biosciences IPO?

(SLDB) raised $130 million in an IPO on Friday, January 26th 2018. The company issued 7,000,000 shares at a price of $18.00-$19.00 per share. J.P. Morgan, Goldman Sachs and Leerink Partners served as the underwriters for the IPO and Nomura and Chardan were co-managers.

Has Solid Biosciences been receiving favorable news coverage?

Press coverage about SLDB stock has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Solid Biosciences earned a media sentiment score of 0.07 on Accern's scale. They also gave headlines about the company an impact score of 47.59 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Solid Biosciences' major shareholders?

Solid Biosciences' stock is owned by many different of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (9.42%), BlackRock Inc. (1.80%), Eventide Asset Management LLC (1.13%), Foresite Capital Management III LLC (0.95%), venBio Select Advisor LLC (0.78%) and Millennium Management LLC (0.76%). View Institutional Ownership Trends for Solid Biosciences.

Which institutional investors are buying Solid Biosciences stock?

SLDB stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., BlackRock Inc., Eventide Asset Management LLC, Foresite Capital Management III LLC, venBio Select Advisor LLC, Millennium Management LLC, Artal Group S.A. and Foresite Capital Management IV LLC. View Insider Buying and Selling for Solid Biosciences.

How do I buy shares of Solid Biosciences?

Shares of SLDB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Solid Biosciences' stock price today?

One share of SLDB stock can currently be purchased for approximately $21.89.

How big of a company is Solid Biosciences?

Solid Biosciences has a market capitalization of $776.26 million. The company earns $-52,110,000.00 in net income (profit) each year or ($2.88) on an earnings per share basis. Solid Biosciences employs 60 workers across the globe.

How can I contact Solid Biosciences?

Solid Biosciences' mailing address is 141 PORTLAND STREET FIFTH FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at 617-337-4680.


MarketBeat Community Rating for Solid Biosciences (SLDB)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  40
MarketBeat's community ratings are surveys of what our community members think about Solid Biosciences and other stocks. Vote "Outperform" if you believe SLDB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLDB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Solid Biosciences (NASDAQ:SLDB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Solid Biosciences in the last 12 months. Their average twelve-month price target is $35.5833, suggesting that the stock has a possible upside of 62.56%. The high price target for SLDB is $52.00 and the low price target for SLDB is $28.00. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldBuyN/A
Consensus Rating Score: 2.502.332.60N/A
Ratings Breakdown: 1 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $35.5833$33.6667$39.80N/A
Price Target Upside: 62.56% upside348.89% upside59.65% upsideN/A

Solid Biosciences (NASDAQ:SLDB) Consensus Price Target History

Price Target History for Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2018Chardan CapitalReiterated RatingBuy$37.50LowView Rating Details
5/10/2018Leerink SwannBoost Price TargetOutperform$14.00 ➝ $28.00LowView Rating Details
3/19/2018NomuraLower Price TargetBuy ➝ Buy$52.00 ➝ $37.00LowView Rating Details
3/15/2018JPMorgan ChaseDowngradeNeutral ➝ Underweight$28.00HighView Rating Details
2/20/2018InstinetInitiated CoverageBuy$52.00HighView Rating Details
2/20/2018Goldman SachsInitiated CoverageNeutral$31.00HighView Rating Details
(Data available from 5/21/2016 forward)

Earnings

Solid Biosciences (NASDAQ:SLDB) Earnings History and Estimates Chart

Earnings by Quarter for Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB) Earnings Estimates

2018 EPS Consensus Estimate: ($2.10)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.45)($0.45)($0.45)
Q2 20181($0.53)($0.53)($0.53)
Q3 20181($0.55)($0.55)($0.55)
Q4 20181($0.57)($0.57)($0.57)

Solid Biosciences (NASDAQ SLDB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2018        
5/10/2018Q1 2018($0.5770)($0.54)ViewN/AView Earnings Details
3/29/2018Q4 2017($0.55)($0.84)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Solid Biosciences (NASDAQ:SLDB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Solid Biosciences (NASDAQ SLDB) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.89%
Insider Trading History for Solid Biosciences (NASDAQ:SLDB)
Institutional Ownership by Quarter for Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ SLDB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/30/2018Life Sciences Maste PerceptiveDirectorBuy1,020,000$16.22$16,544,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Solid Biosciences (NASDAQ SLDB) News Headlines

Source:
DateHeadline
Solid Biosciences Announces New Preclinical Data at the American Society of Gene and Cell Therapy Annual MeetingSolid Biosciences Announces New Preclinical Data at the American Society of Gene and Cell Therapy Annual Meeting
www.streetinsider.com - May 19 at 8:51 AM
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Solid Biosciences Inc. to Contact the FirmFINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Solid Biosciences Inc. to Contact the Firm
finance.yahoo.com - May 19 at 8:51 AM
Rounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic InnovatorsRounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic Innovators
seekingalpha.com - May 17 at 8:51 AM
-$0.52 Earnings Per Share Expected for Solid Biosciences (SLDB) This Quarter-$0.52 Earnings Per Share Expected for Solid Biosciences (SLDB) This Quarter
www.americanbankingnews.com - May 17 at 1:25 AM
Solid Biosciences Announces Upcoming Preclinical Data PresentationsSolid Biosciences Announces Upcoming Preclinical Data Presentations
finance.yahoo.com - May 16 at 9:00 AM
Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Solid Biosciences, Inc. on Behalf of InvestorsKessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Solid Biosciences, Inc. on Behalf of Investors
www.finanznachrichten.de - May 14 at 3:23 PM
INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The FirmINVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The Firm
finance.yahoo.com - May 14 at 3:23 PM
Q2 2018 Earnings Estimate for Solid Biosciences (SLDB) Issued By Leerink SwannQ2 2018 Earnings Estimate for Solid Biosciences (SLDB) Issued By Leerink Swann
www.americanbankingnews.com - May 14 at 1:40 AM
Rounds Report: Solid Biosciences Garnered Big Profits While Stellar FDA Due Diligence To Help NektarRounds Report: Solid Biosciences Garnered Big Profits While Stellar FDA Due Diligence To Help Nektar
seekingalpha.com - May 13 at 8:43 AM
MAY 29 DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The FirmMAY 29 DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The Firm
finance.yahoo.com - May 12 at 3:23 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming DeadlineSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline
finance.yahoo.com - May 12 at 8:28 AM
Solid Biosciences (SLDB) Issues  Earnings Results, Beats Expectations By $0.04 EPSSolid Biosciences (SLDB) Issues Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - May 11 at 8:59 PM
Solid Biosciences (SLDB) vs. REGENXBIO (RGNX) Financial ComparisonSolid Biosciences (SLDB) vs. REGENXBIO (RGNX) Financial Comparison
www.americanbankingnews.com - May 11 at 3:06 PM
Rounds Report: Solid Biosciences Rallied While Inspire Medical System Witnessed Substantial Insider PurchasesRounds Report: Solid Biosciences Rallied While Inspire Medical System Witnessed Substantial Insider Purchases
seekingalpha.com - May 11 at 8:39 AM
Solid Biosciences (SLDB) Rating Reiterated by Chardan CapitalSolid Biosciences (SLDB) Rating Reiterated by Chardan Capital
www.americanbankingnews.com - May 10 at 5:15 PM
Solid Biosciences (SLDB) PT Raised to $28.00 at Leerink SwannSolid Biosciences (SLDB) PT Raised to $28.00 at Leerink Swann
www.americanbankingnews.com - May 10 at 5:15 PM
Kaskela Law LLC: Deadline Alert for Solid Biosciences, Inc. Shareholders in Class Action Lawsuit - SLDBKaskela Law LLC: Deadline Alert for Solid Biosciences, Inc. Shareholders in Class Action Lawsuit - SLDB
www.finanznachrichten.de - May 9 at 8:46 AM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The FirmIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The Firm
finance.yahoo.com - May 9 at 8:46 AM
PAWAR LAW NOTICE: Important May 29, 2018 Lead Plaintiff Deadline in Solid Biosciences Inc. Class Action - SLDBPAWAR LAW NOTICE: Important May 29, 2018 Lead Plaintiff Deadline in Solid Biosciences Inc. Class Action - SLDB
finance.yahoo.com - May 9 at 8:46 AM
Deadline Alert for Solid Biosciences, Inc. Shareholders in Class Action Lawsuit - SLDBDeadline Alert for Solid Biosciences, Inc. Shareholders in Class Action Lawsuit - SLDB
finance.yahoo.com - May 9 at 8:46 AM
The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)
finance.yahoo.com - May 8 at 3:23 PM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors With Losses In Excess of $100,000 to Contact The Firm
finance.yahoo.com - May 8 at 8:45 AM
Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Solid Biosciences, Inc. Investors – SLDBKessler Topaz Meltzer & Check, LLP - Deadline Reminder for Solid Biosciences, Inc. Investors – SLDB
globenewswire.com - May 7 at 3:24 PM
Solid Biosciences (SLDB) Given Average Recommendation of "Hold" by AnalystsSolid Biosciences (SLDB) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 7 at 8:06 AM
Kaskela Law LLC: Shareholder Class Action Filed Against Solid Biosciences, Inc. - SLDBKaskela Law LLC: Shareholder Class Action Filed Against Solid Biosciences, Inc. - SLDB
feeds.benzinga.com - May 6 at 3:16 PM
Rounds Report: Solid Biosciences Bull Charged Ahead While Portola Gained FDA Approval Of AndexXaRounds Report: Solid Biosciences Bull Charged Ahead While Portola Gained FDA Approval Of AndexXa
seekingalpha.com - May 6 at 8:42 AM
SOLID BIOSCIENCES SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid ...SOLID BIOSCIENCES SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid ...
www.businesswire.com - May 5 at 8:38 AM
SLDB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Solid Biosciences Inc. and a Lead Plaintiff Deadline of May 29, 2018SLDB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Solid Biosciences Inc. and a Lead Plaintiff Deadline of May 29, 2018
finance.yahoo.com - May 4 at 8:40 AM
WeissLaw LLP: Solid Biosciences Inc. is the Subject of a Legal InvestigationWeissLaw LLP: Solid Biosciences Inc. is the Subject of a Legal Investigation
www.prnewswire.com - May 2 at 7:55 PM
Solid Biosciences (SLDB) Upgraded by ValuEngine to HoldSolid Biosciences (SLDB) Upgraded by ValuEngine to Hold
www.americanbankingnews.com - May 2 at 6:12 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - SLDBSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - SLDB
finance.yahoo.com - May 2 at 3:22 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Solid Biosciences Inc. (SLDB) and Lead Plaintiff Deadline - May 28, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Solid Biosciences Inc. (SLDB) and Lead Plaintiff Deadline - May 28, 2018
finance.yahoo.com - May 2 at 3:22 PM
The Klein Law Firm Reminds Investors of a Class Action on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)The Klein Law Firm Reminds Investors of a Class Action on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)
feeds.benzinga.com - May 1 at 6:12 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - SLDBEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - SLDB
finance.yahoo.com - May 1 at 3:23 PM
Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6%Solid Biosciences moving closer to removal of clinical hold on early-stage study of DMD candidate SGT-001; shares up 6%
seekingalpha.com - April 30 at 3:23 PM
SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Solid Biosciences, Inc. - SLDBSHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Solid Biosciences, Inc. - SLDB
finance.yahoo.com - April 30 at 3:23 PM
Zacks: Analysts Anticipate Solid Biosciences (SLDB) Will Announce Earnings of -$0.43 Per ShareZacks: Analysts Anticipate Solid Biosciences (SLDB) Will Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - April 29 at 11:12 AM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Solid Biosciences Inc. (Nasdaq: SLDB) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Solid Biosciences Inc. (Nasdaq: SLDB) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - April 29 at 8:21 AM
Short Interest in Solid Biosciences (SLDB) Decreases By 42.3%Short Interest in Solid Biosciences (SLDB) Decreases By 42.3%
www.americanbankingnews.com - April 29 at 3:12 AM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - SLDBSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - SLDB
www.prnewswire.com - April 28 at 9:34 AM
SLDB LOSS NOTICE: Rosen Law Firm Reminds Solid Biosciences Inc. Investors of Important Deadline in Class ActionSLDB LOSS NOTICE: Rosen Law Firm Reminds Solid Biosciences Inc. Investors of Important Deadline in Class Action
www.bizjournals.com - April 28 at 8:36 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 – SLDBINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 – SLDB
feeds.benzinga.com - April 26 at 4:12 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Solid Biosciences Inc. (SLDB) and Lead Plaintiff Deadline - May 28, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Solid Biosciences Inc. (SLDB) and Lead Plaintiff Deadline - May 28, 2018
finance.yahoo.com - April 26 at 3:23 PM
Rounds Report: Solid Continued Its Comeback And An Improved FDA Policy To Help NektarRounds Report: Solid Continued Its Comeback And An Improved FDA Policy To Help Nektar
seekingalpha.com - April 26 at 8:34 AM
The Klein Law Firm Notifies Investors of Commencement of a Class Action on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)The Klein Law Firm Notifies Investors of Commencement of a Class Action on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)
finance.yahoo.com - April 26 at 8:34 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 – SLDBEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 – SLDB
finance.yahoo.com - April 25 at 8:23 AM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors to Contact The FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Solid Biosciences Inc. and Reminds Investors to Contact The Firm
finance.yahoo.com - April 24 at 8:29 AM
Johnson Fistel, Announces Investigations of FAT Brands Inc., Solid Biosciences Inc., and Grupo Televisa S.A.B.; Investors with Losses Encouraged to Contact FirmJohnson Fistel, Announces Investigations of FAT Brands Inc., Solid Biosciences Inc., and Grupo Televisa S.A.B.; Investors with Losses Encouraged to Contact Firm
www.prnewswire.com - April 22 at 2:07 PM
Rounds Report: Solid Biosciences Is Making A Comeback While Improving FDA Policies To Favor NektarRounds Report: Solid Biosciences Is Making A Comeback While Improving FDA Policies To Favor Nektar
seekingalpha.com - April 21 at 8:18 AM
SOLID BIOSCIENCES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline ...SOLID BIOSCIENCES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline ...
www.businesswire.com - April 21 at 8:18 AM

SEC Filings

Solid Biosciences (NASDAQ:SLDB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Solid Biosciences (NASDAQ SLDB) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.